Pilihan
Invitation - 2026 Half-Year Results Conference for Analysts and Investors
Ladies and Gentlemen,
We invite you to the Ascom Holding Ltd Analyst and Investor Conference on the occasion of the publication of the 2026 half-year results:
Date: Wednesday, 29 July 2026
Start: 10:00 a.m. CEST
Format: Online, via Microsoft Teams
Speakers: David Hale, CEO; Kalina Scott, CFO
Video webinar with Q&A session
The conference will be streamed via Microsoft Teams. The conference will be conducted in English.
Please use the following link to join.
Microsoft Teams Meeting: Link
Meeting ID: 314 619 521 920 748
Passcode: Qf7Ng2Yq
Dial in by phone: +41 43 216 35 11
Phone conference ID: 107264094#
If you are joining via smartphone, please download the Teams app in advance. Please dial in five minutes before the start.
Following the presentation, participants can ask questions live or in writing via chat during the Q&A session.
Ascom will publish the press release, the presentation, and the 2026 Half-Year Report on July 29, 2026, at 7:00 a.m. CEST on www.ascom.com.
Best regards,
Kalina Scott
CFO
Attachment
Ascom_Invitation_HalfYearConference_2026
Copyright 2026 GlobeNewswire, Inc.
.png)

Berita Lainnya
Hong Kong Restaurants Claim Top Two Spots in Asia' 50 Best
Digital Realty Targets Nearly S$7 Billion Investment to Strengthen Singapore as Asia Pacific AI Hub
Denodo Advances Trusted Data Foundations for Agentic AI with New Amazon Web Services (AWS) Integrations
CGTN: Cara Tiongkok dan Spanyol mempererat hubungan di tengah ketidakpastian global
European Medicines Agency Expedites Assessment of Revolution Medicines' Daraxonrasib Under Phased Review Process
MOVA LumeGret Debuts S4800 and Expands Residential Energy Portfolio at Intersolar Europe 2026
Meltwater's Antony Cousins Named to PRWeek's AI 25: Class of 2026
House of Doge Completes Merger with Brag House Holdings and Set to Trade on Nasdaq Under Ticker "HODO"
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
CCTE Successfully Concludes Thorium Fuel Irradiation, Surpasses 60GWd/MTU Burnup in INL Reactor
Amii Fuels Canada's AI Momentum as Upper Bound Opens with 53% Growth and 11,000 Global Attendees
BHAV Acquisition Corp Announces Closing of $100 Million Initial Public Offering